LH

LH

USD

Labcorp Holdings Inc. Common Stock

$252.720+5.880 (2.382%)

Preço em tempo real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$246.840

Máximo

$252.760

Mínimo

$244.520

Volume

0.69M

Fundamentos da empresa

Capitalização de mercado

21.0B

Setor

Diagnostics & Research

País

United States

Estatísticas de negociação

Volume médio

0.62M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $209.38Atual $252.720Máximo $293.72

Notícias relacionadas

Analyst Upgrades

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

UBS analyst Kevin Caliendo maintains Labcorp Hldgs with a Buy and lowers the price target from $325 to $320.

Ver mais
UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320
Reuters

Labcorp cuts growth outlook for research unit as biotech funding crunch persists

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

Ver mais
Labcorp cuts growth outlook for research unit as biotech funding crunch persists
Analyst Upgrades

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth.

Ver mais
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
PR Newswire

Labcorp Announces 2025 Third Quarter Results

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended...

Ver mais
Labcorp Announces 2025 Third Quarter Results
PR Newswire

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...

Ver mais
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.